Eiger Biopharmaceuticals Inc (EIGRQ)
OTCMKTS: EIGRQ · Delayed Price · USD
2.690
-0.350 (-11.51%)
May 3, 2024, 3:33 PM EDT - Market closed

Eiger Biopharmaceuticals Market Cap

Eiger Biopharmaceuticals has a market cap or net worth of $2.55 million as of May 3, 2024. Its market cap has decreased by -93.62% in one year.

Market Cap
2.55M
Enterprise Value
18.32M
1-Year Change
-93.62%
Ranking
n/a
Category
Stock Price
$2.69

Market Cap Chart

Since January 30, 2014, Eiger Biopharmaceuticals's market cap has decreased from $140.60M to $2.55M, a decrease of -98.18%. That is a compound annual growth rate of -32.50%.

History

DateMarket Cap% Change
Apr 10, 20242.60M-7.14%
Apr 9, 20242.80M-9.68%
Apr 8, 20243.10M-8.82%
Apr 5, 20243.40M3.03%
Apr 4, 20243.30M37.50%
Apr 3, 20242.40M26.32%
Apr 2, 20241.90M-9.52%
Apr 1, 20242.10M-71.62%
Mar 28, 20247.40M-
Mar 27, 20247.40M-6.33%
Mar 26, 20247.90M-4.82%
Mar 25, 20248.30M-2.35%
Mar 22, 20248.50M-3.41%
Mar 21, 20248.80M11.39%
Mar 20, 20247.90M11.27%
Mar 19, 20247.10M-6.58%
Mar 18, 20247.60M-
Mar 15, 20247.60M-3.80%
Mar 14, 20247.90M-11.24%
Mar 13, 20248.90M2.30%
Mar 12, 20248.70M-13.00%
Mar 11, 202410.00M-1.96%
Mar 8, 202410.20M-3.77%
Mar 7, 202410.60M4.95%
Mar 6, 202410.10M-1.94%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 718.69B
Novo Nordisk 548.10B
UnitedHealth Group 453.57B
Johnson & Johnson 361.27B
Merck & Co. 324.84B
AbbVie 284.74B
AstraZeneca 234.97B
Thermo Fisher 218.05B
Market Cap Rankings